FORWARD FEATURES CALENDAR

Funds

Blockchain

VNX completes first blockchain tech VC deal in Europe

VNX Exchange, a Luxembourg-based digital asset investment platform, has completed the first VC deal in Europe utilising blockchain tech. The deal sees the issue of EUR1.1 million of asset-backed tokens linked to the investment into Streami Inc, a South Korean blockchain company. Issued on the Ethereum blockchain ERC-20, the asset-backed

Permira funds to acquire European CNS specialty pharmaceutical company Neuraxpharm

A company backed by global private equity firm Permira, has agreed to acquire Neuraxpharm, a European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS) from funds advised by Apax Partners. Financial details of the transaction have not been disclosed.   With its unique understanding of the

ARQIS advises AVS on SRV Verkehrstechnik acquisition

ARQIS has advised AVS Verkehrssicherung on the acquisition of SRV Verkehrstechnik.SRV was founded in 1990 to meet the high demand for infrastructure services in the former East German states. The professional application of white or yellow road markings in paint, hot or cold plastic is the specialty of SRV. Services

AMP Capital acquires infra tech fibre business VX Fiber

AMP Capital has agreed to acquire a majority stake in VX Fiber, an international infra tech fibre business headquartered in Sweden, on behalf of investors in its infrastructure equity strategy. VX Fiber has existing operations in South Africa and the UK and is targeting an advanced pipeline of opportunities in the

Funds advised by Apax Partners sell controlling shareholding in Neuraxpharm

Funds advised by Apax Partners (the “Apax Funds”) have agreed to sell their controlling stake in Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system disorders (CNS), to funds advised by Permira. Financial details of the transaction have not been disclosed.       With a

Medicxi holds closing of its first EUR200m Secondary Fund

Medicxi, a European life sciences investment firm, has held the closing of Medicxi Secondary 1 (MS1) in connection with the completion of an “Exit & Reinvest” type of structured secondary transaction. The interests in six clinical and preclinical stage companies held by Index Ventures Life VI, a dedicated life sciences fund

Odyssey Investment Partners to acquire ProPharma Group

Odyssey Investment Partners (Odyssey) is to acquire ProPharma Group from Linden Capital Partners. Financial terms of the transaction have not been disclosed. Founded in 2001, ProPharma Group is a leading provider of regulatory and compliance services to pharmaceutical, biotechnology and medical device customers. The Company’s primary service offerings include regulatory affairs,

BGF to become cornerstone investor in Calnex Solutions

BGF is investing in Calnex Solutions plc, an established provider of test and measurement solutions for the global telecommunications sector, as part of its proposed admission to trading on AIM. The admission is expected to take place on 5 October 2020.     Headquartered in Linlithgow and founded in 2006, Calnex designs

Auxo Investment Partners acquires niche manufacturers Paramount Tube and Euclid Medical

Private investment firm Auxo Investment Partners has partnered with existing management to acquire Paramount Tube and Euclid Medical, which operate under the Precision Products Group (PPG) brand. The deal, terms of which have not been disclosed, marks Auxo’s seventh acquisition in the firm’s inaugural investment fund, Auxo Growth Holdings I LLC,

Inverness Graham-backed KICTeam acquires Teknipure

Inverness Graham Investments, a private investment firm targeting tech-enabled manufacturing, service and software companies, has added Teknipure to it announced today that its proprietary cleaning consumables platform,  KICTeam.Based in Mesa, Arizona, Teknipure is a specialist in the design, manufacture and marketing of specialty cleaning products targeting regulated and contamination-controlled fabrication

Events

12 November, 2026 – 5:00 pm

Directory Listings